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Abstract 
 
Polymorphisms of the catechol-O-methyl transferase (COMT) gene have been associated with 
alcoholism, suggesting that alterations in the metabolism of catecholamines may be a critical 
component of the neuropathology of alcoholism. In the current experiments, the COMT inhibitor 
tolcapone was utilized in an operant behavioral model of reinforcer-seeking and drinking to 
determine if this compound was capable of remediating the excessive seeking and drinking 
phenotype of the alcohol-preferring P rat. Tolcapone was administered to male and female 
alcohol-reinforced P and Wistar rats. Additionally, tolcapone was administered to male sucrose-
reinforced P and Wistar rats to determine if its effects also extended to a natural reinforcer. 
Animals were trained to make an operant response that resulted in 20 min uninterrupted access to 
the reinforcer solutions. Tolcapone had no effect in female rats on either seeking or consumption 
of ethanol. However, reductions of both reinforcer seeking and consumption were observed in 
male P rats, but only of seeking in Wistars. In separate experiments, using reinforcer naïve male 
and female animals, COMT expression was assessed via Western Blot analysis. Sex differences 
in COMT expression were also observed, where male P rats exhibited a marked reduction in 
protein expression relative to females in the PFC. Sex differences were not observed for Wistars 
or in the striatum and hippocampus. These data complement our previous findings in which 
tolcapone reduced cue-evoked responses in P rats and further suggest clinical utility of COMT 
inhibitors in the treatment of addiction disorders, specifically in male high drinkers.   
 
 
Introduction 
 
Differences in catechol-o-methyl transferase (COMT) genotype have been linked to illicit 
drug use (Chen et al., 2014) and polysubstance abuse (Vandenbergh et al., 1997). However, with 
regard to alcohol use, the role of COMT is unclear. Associations between allelic variations in 
COMT and drinking behaviors are mixed, with some finding associations (Hendershot et al., 
2012; Kauhanen et al., 2000; Tammimäki et al., 2008; Tiihonen et al., 1999; Wang et al., 2001), 
while others do not (Hallikainen et al., 2000; Kweon et al., 2005; Samochowiec et al., 2006; 
Shibuya et al., 1999). Similarly, the relationship between COMT and the propensity to relapse is 
complex, and while an association has been observed  (Wojnar et al., 2009) other studies have 
failed to find one (Foroud et al., 2007; Köhnke et al., 2003).  COMT is hypothesized to play a 
role in executive function (Egan et al., 2001; Goldberg et al., 2003; Tammimäki and Mannisto, 
2010) and deficits in executive function are associated with risk for alcohol use disorder (AUD; 
Finn et al., 2009). As such, manipulations of COMT may ameliorate maladaptive drug seeking 
and taking behaviors.  
Alcohol preferring (P) rats are selectively bred for free-choice alcohol preference, exhibit 
excessive reward consumption (Lankford et al., 1991; McCane et al., 2014), and deficits in 
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executive function (Beckwith and Czachowski, 2016; Linsenbardt et al., 2016). Additionally, 
reduced dopamine (DA) levels in the medial prefrontal cortex (PFC) have been observed in P 
rats, when compared with their progenitor strain, the Wistar rat (Engleman et al., 2006). Given 
the well documented role of COMT in degrading cortical DA (Käenmäki et al., 2010; Yavich et 
al., 2007), we hypothesized that differences in COMT may be associated with the excessive 
alcohol seeking and consuming phenotype of the P rats. Using the COMT inhibitor tolcapone, 
we have previously observed a tolcapone-mediated suppression of cued ethanol seeking in male 
P rats but not Wistars, with no effect on free choice ethanol consumption in either strain 
(McCane et al., 2014). However, it is unclear how differences in COMT might account for 
differences in tolcapone’s efficacy. Strain differences in tolcapone’s efficacy may be attributable 
to differences in COMT, and would suggest a link between COMT and an excessive alcohol 
seeking/drinking phenotype.   
Sex has been shown to mediate the relationship between allelic differences in COMT and 
behavior (Harrison and Tunbridge, 2008). The COMT promoter region contains 2 estrogen 
response elements (Xie et al., 1999) that can inhibit the formation of COMT (Jiang et al., 2003). 
With regard to alcohol drinking, Tammimäki et al. (2008) showed that manipulating COMT  
affected consumption in male  but not female mice. In the absence of COMT manipulations, sex 
specific effects on alcohol behaviors have also been reported. For instance, female rodents show 
overall higher ethanol intakes than males (Lancaster and Spiegel, 1992; Morales et al., 2014; 
Tammimäki et al., 2008). We have previously shown that COMT modulation reduces drinking in 
male P rats (McCane et al., 2014) but the effects of tolcapone on the drinking behaviors of 
female P rats is unknown. Therefore, the current study assessed the effects of tolcapone in both 
male and female P and Wistar rats.  
Working under the hypothesis that differences in COMT are associated with aberrant 
ethanol seeking and intake, the current project sought to investigate the influence of alterations in 
COMT activity and expression on alcohol seeking and drinking. While sex-linked differences in 
COMT protein expression (Schendzielorz et al., 2011) and effects of tolcapone are documented 
(Tunbridge et al., 2013), it is currently unknown if COMT expression differs between male and 
female Wistar and P rats.  Thus it is unclear whether pharmacotherapies targeting COMT will be 
efficacious in both sexes. Therefore, an additional aim of the current project was to quantify sex 
and strain differences in COMT using western blot analyses to determine whether these 
differences in COMT expression might be associated with variances in the effects of tolcapone. 
 
Materials and Methods  
 
All procedures were approved by the IUPUI School of Science Institutional Animal Care and 
Use Committee and were in accordance with the National Institutes of Health Guidelines for the 
Care and Use of Laboratory Animals (2011). 
 
Subjects: Subjects were alcohol naïve adult male (N=32) and female (N=27) Wistar rats (Harlan, 
Indianapolis, IN) and male (N=30) and female (N=28) P rats (75th and 76th generations; Indiana 
University, IN) for all experiments. Animals were single housed in a climate controlled room on 
a 12-hour light dark cycle. All animals were handled one week prior to testing and were 
approximately 12 weeks of age at the start of testing.  
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Intermittent access drinking protocol (IAP): A modified two-bottle free choice drinking protocol 
as described by Simms et al. (2008)  was implemented to expose animals to the liquid solutions 
later used during conditioning and to initiate solution consumption. Subjects were divided by 
strain, drinking solution and sex which resulted in six groups:  alcohol male P (n = 9), alcohol 
male Wistar (n = 12), sucrose male P (n = 9), sucrose male Wistar (n = 8), alcohol female P 
(n=15) and alcohol female Wistar (n = 16).  One hour after the start of the dark cycle, all water 
bottles were replaced with two bottles, one containing water and the other containing either 
sucrose (1%) or ethanol (20%), counterbalanced by side. After 24 hours of two-bottle access, 
bottles were removed, fluid intake was measured and the initial water bottle was replaced. 
Animals had access to their respective solutions 24 hr/d for 3 d/wk (M, W, F) over the course of 
a four-week period. Animals were weighed immediately before bottle placement to calculate 
grams of sucrose or ethanol intake per kilogram of body weight.  
 
Procedural separation of seeking and drinking (PSSD) training: All operant conditioning 
sessions were conducted in modular operant chambers (30 x 30 x 24.5 cm; Med Associates, St. 
Albans, VT) equipped with a house light, retractable lever and a retractable graduated cylinder 
tube fitted with stainless steel spouts containing double ball bearings to reduce leakage.   
 
After 4 weeks of IAP drinking, all animals were transitioned to an operant conditioning 
paradigm. To facilitate lever press training, animals were water restricted in their home cages 24-
hours prior to the first conditioning session. Animals were then hand shaped to lever press on a 
fixed ratio (FR) 1 schedule for 30 seconds of access to water. Animals remained water restricted 
for approximately one week on an FR1 schedule for water access, which was shifted from 30 
seconds to 15 seconds after two consecutive days of 5 or more responses. After successful (> 10) 
lever press responses for water during a 30-minute session, animals were given ad libitum water 
in their home cages and the operant conditioning reinforcer was changed from water to either 
sucrose (1%) or ethanol (10%), depending on previous grouping in the IAP. Animals continued 
lever press training and the FR1 schedule was gradually increased to an FR4 over the course of a 
week. After successful (> 8) responding under an FR4, animals were transitioned to a response 
requirement (RR) 4 schedule where four responses were reinforced with 20 minutes of access to 
sucrose or ethanol. Animals were then gradually increased to an RR10, which was maintained 
for two weeks prior to drug testing. Acquisition of operant responding took approximately, six 
weeks.  
 
PSSD consummatory test phase: After animals responded for an RR10  for 4/5 days a week, a 
four week consummatory testing phase was initiated in which animals received intraperitoneal 
(IP) injections of tolcapone (Valeant Pharmaceuticals; 0; 3.0; 10.0; 30.0 mg/kg) in a balanced 
design two hours prior to testing on one day (Wednesday) each week. Tolcapone was prepared 
by dissolving crushed tablets in sterile saline (vehicle; Lapish et al., 2009; McCane et al., 2014). 
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Tablets were fully dissolved (i.e., not in suspension) prior to drug administration. This method of 
drug preparation and delivery reliably enhances evoked DA efflux as measured by microdialysis 
(Lapish et al., 2009). The maximum dose chosen has been consistently observed to inhibit 
COMT in mice (Tammimäki et al., 2016) and is within the narrow range of drug concentrations 
which inhibit COMT (Borges et al., 1997). On testing days, the reinforcement schedule was 
changed to an RR1. The following day (Thursday) animals were moved to an RR5 and an RR10 
was implemented all other days. Intakes (g/kg) were determined from change in fluid volume of 
the sipper tube and daily body weights.   
 
PSSD appetitive test phase: Following the consummatory phase of testing, the response 
requirement was gradually increased to an RR20, which was maintained for two weeks prior to 
drug testing. After consistent responding on an RR20, a four week appetitive testing phase was 
initiated in which animals received IP injections of tolcapone (0; 3.0; 10.0; 30.0 mg/kg) in a 
balanced design two hours prior to testing on one day each week (Wednesday). On testing days, 
all animals were given an extinction session. During extinction, retractable sippers containing 
reinforcers to control for scent cues were present but lever pressing was not reinforced. The 
following day (Thursday) animals were moved up to an RR10 and an RR20 was implemented all 
other days. Once a week, animals would receive a vehicle injection two hours prior to a 
reinforced session to control for the possibility that animals may associate an injection with an 
extinction session.  
 
Western Blot: Following behavioral testing, separate cohorts of rats were used for western blot 
analyses. We first assessed COMT protein levels in male P and Wistar rats to determine whether 
strain differences in COMT were present. Following behavioral testing, we subsequently 
assessed sex differences to better understand how differences in COMT protein level may be 
associated with behavioral differences observed. Alcohol naïve male and female P (n = 11-12 
male, n=13 female) and Wistar (n = 12 male, n=11 female) rats were euthanized and brains were 
extracted. Coordinates were based on the rat brain atlas (Paxinos and Watson, 2007). Tissue 
from the medial (m)PFC (AP, 3.2; ML, 0.6; DV, -2.5), hippocampus (AP, -4.16; ML, 2.8; DV, -
3.2), and ventral striatum (vST; AP, 1.6; ML, 1.5; DV, -6.7) were dissected for Western Blot 
analyses. These regions were chosen because of their known involvement in drug seeking 
behavior and previous evidence of COMT activity. Tissue was placed in a Potter-Elvehjem tissue 
grinder and homogenized in 2% Sodium Dodecyl Sulfate (SDS). Protein concentration was 
determined by bicinchoninic acid assay kit (Pierce Biotechnology, Inc., Rockford, IL., USA). 
Proteins were separated on 12% SDS-Page gels (Bio-Rad) then transferred using a Transblot 
Turbo System (Bio-Rad Laboratories, USA) to nitrocellulose paper via 1.3A 25V for 7 minutes 
(COMT ~24 Kd). The blots were then stained with Ponceau S (BP10-10, Thermo Fisher 
Scientific, Waltham, MA., USA) and scanned as a TIFF image on Epson V700 photo scanner for 
loading control analysis. For immunostaining, the blot was blocked for 1 hour in TBS-T (TBS 
with 0.1% Tween 20) and 5% nonfat dry milk. The blot was then incubated in anti-COMT 
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(BDB611970, BD Transduction Laboratory) diluted 1/1000, for 18 hours at 4°. Then the blot 
was rinsed in TBS-T with 5% nonfat dry milk. The second antibody (Goat anti-Mouse Alexa 
790) was diluted 1/10,000 in TBS-T with 5% nonfat dry milk. The blot was incubated in the 
secondary at room temperature for 1 hour on a rocker and then rinsed in TBS. As a control, gels 
were run in duplicate with one gel receiving no primary antibody. Bands were visualized with 
the LI-Cor CLx Odyssey Infrared Imaging System (Imaging system Li-Cor Inc, Lincoln, NE). 
 
Data analysis and statistics:  All statistical analyses were performed in R (http://www.r-
project.org). All group effects were first assessed by analysis of variance (ANOVA) and 
Dunnett’s post-hoc was used for all multiple comparison procedures when appropriate.  For 
Western blots, to control for loading differences, Ponceau signal intensity was assessed between 
male versus female Wistars and P rats via unpaired t-tests in the mPFC, hippocampus, and vST, 
separately. To compare COMT protein levels between sexes for each brain region for each 
treatment, COMT, the following formula was used: Total COMT/Ponceau signal intensity. To 
compare COMT protein levels between strains, COMT was normalized by total protein content 
and then compared across strains. To get a normalized value for each animal, the following 
formula was used: (total COMT/total protein) / (averaged total COMT/total protein of all Wistar 
rats). Data are presented as normalized to Wistar (%). 
 
Results  
 
IAP 
 
A three-way repeated measures ANOVA (RMANOVA) of ethanol intake by strain, sex, and day 
indicated that female rats consumed significantly more ethanol than males overall all [main 
effect of sex: F(1,46)=22.89, p<0.001].  Data were therefore stratified by sex.  
 
In females, P rats consumed more ethanol than Wistars [two-way RMANOVA intake by strain 
and day, main effect of strain: F(1, 28) =32.52, p<0.001] while both strains increased their 
ethanol intake over days [main effect of day: F(1,28)=9.92,p=0.0039, Fig 1].  
 
Similarly, in male rats, P rats drank more ethanol than Wistars [two-way RMANOVA, intake by 
strain and day, main effect of strain: F(1,18) = 30.9, p < 0.0001] and both P rats and Wistars 
increased their ethanol [main effect of day: F(11,208) = 3.2, p=0.0005; Fig 1] intake over days.  
 
Additionally, in sucrose drinking male rats, P rats drank more than Wistars [RMANOVA, intake 
by strain and day, main effect of strain: F(1,12) = 131.6, p < 0.001] but Wistars and  P rats 
showed different patterns of intake over days [strain × day interaction: F(11,181) = 9.4, p < 
0.001; Fig 2], where only P rats exhibited a change in intake over days [main effect of day: 
F(1,8) = 30.76, p = 0.0005].  
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PSSD and Tolcapone 
 
In the consummatory test phase, there were significant three way [three-way RMANOVA, group 
× strain × treatment: F(1,32) = 4.7, p = 0.03] and two way [strain × treatment: F(1,32)=8.8, 
p=0.006] interactions in male rats. Data were next stratified by strain which yielded a significant 
group by treatment interaction in P rats [F(1,16)=5.9, p=0.03] but not Wistars 
[F(1,16)=0.07,p=0.8]. In P rats, there was main effect of treatment on both ethanol [F(1,8)=7.1, 
p=0.03; Fig 3A1] and sucrose [F(1,8)=9.8,p=0.01; Fig 3B] intake. There was no main effect of 
treatment in the Wistars [F(1,16)=1.4,p=0.3]. 
 
To test the a priori hypothesis that tolcapone’s effects may differ by sex, tolcapone was 
administered to a separate group of female rats during the consummatory test phase using 
ethanol as the reinforcer. A null effect of tolcapone on ethanol intake in females was observed 
[two-way RMANOVA, intake by strain and treatment, main effect of treatment: F(3,82)=0.23, 
p=0.9, Fig 3A2]. 
 
In the appetitive test phase, male rats were stratified by strain which was justified by a significant 
main effect of strain [F(1,29)=24.1, p<0.001]. Significant main effects of treatment were 
observed in both Wistars [F(1,15)=10.9, p=0.005] and P rats [F(1,15)=29.7, p<0.001] on lever-
press responding. For both strains, Dunnett’s post hoc test indicated that the effect of tolcapone 
to decrease seeking was driven by the 30.0 mg/kg dose relative to vehicle [p<0.05, Fig 4]. There 
was no effect of tolcapone on latency to first response [F(1,31)=0.33, p=0.57] or latency to first 
lick [F(1,31)=0.06,p=0.81] , suggesting that tolcapone treatment did not alter locomotor activity.  
In females, there was a significant main effect of strain [F(1,29)=23.63, p<0.001] with P rats 
responding more than Wistars overall,  however, tolcapone had no effect on seeking in either P 
[main effect of treatment: p=.64] or Wistar rats [p=.99].   
 
 
COMT protein expression 
 
For western blot analyses, we tested two separate hypotheses yielding two different blots. In the 
first western blot, strain differences in protein expression were assessed in male rats. There were 
significant decreases in COMT in the P rats compared to Wistars in the PFC [t(12)=3.5, 
p=0.004], in the hippocampus [t(12)=3.4, p=0.006] and in the vST [t(12)=2.5, p=0.03;Fig 5A]. 
Sex differences were next evaluated in separate blots. There were no differences between sexes 
in Ponceau signal intensity in each brain region for each treatment (independent samples t-tests, 
p>0.05; data not shown). Furthermore, there were no significant differences in the PFC 
[t(21)=0.687, p=0.4996], hippocampus  [t(21)=0.0481, p=0.9621], or vST [t(21)=0.4131, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
p=0.6837] when examining sex differences in Wistars for Total COMT/Ponceau signal intensity 
(Fig. 5B). Interestingly, female P rats had higher Total COMT/Ponceau signal intensity in the 
PFC compared to male P rats [t(23)=3.784, p=0.0010] (Fig 5C). These differences were not 
observed in the hippocampus [t(22)=0.09352, p=0.9263] or vST [t(23)=0.1294, p=0.8981].  
 
 
Discussion 
 
In our previous study, we observed that tolcapone treatment resulted in a reduction in 
cued reward consumption in male P but not Wistar rats (McCane et al., 2014). Additionally, we 
observed null effects of tolcapone on free choice drinking for both P and Wistar rats (McCane et 
al., 2014). Importantly, both these findings were observed in male rats and females were not 
tested. Here we report that tolcapone reduces “earned” reinforcer consumption in male P but not 
Wistar rats with no effect on females of either strain. In other words, consummatory behavior 
was consistently modulated by tolcapone under conditions of cued, limited access, but not in a 
free choice condition (IAP; McCane et al., 2014). Therefore, we hypothesize that the behavioral 
effects of this compound are not mediated by a general suppression of consummatory behavior 
but rather an attenuation of the salience of reward-paired cues. Moreover, since both sex and 
strain differences in COMT expression were detected in the PFC, we further hypothesize that 
COMT-mediated differences in cortical catecholamine levels contribute to the efficacy of 
tolcapone. 
Our previous findings showed that tolcapone attenuated cued ethanol consumption in 
Wistars, but only in high drinkers (McCane et al., 2014). However, in the current study, 
tolcapone had no effect in female rats of either strain, both of which drank more than their male 
counterparts. It is not likely that alcohol history alone can explain the differences in tolcapone’s 
efficacy. In our previous study (McCane et al., 2014) we observed that during the IAP, male P 
rats drank levels of ethanol comparable to what females in the same paradigm consume in the 
current experiments. Additionally, we have previously observed that tolcapone was more 
efficacious in high drinkers, compared to low drinkers (McCane et al, 2014). As such, one might 
hypothesize that in females tolcapone would be more efficacious, which was not the case, 
indicating sex-mediated differences in COMT, independent of level of intake. Our findings are  
consistent with results obtained from Tammimäki et al. (2008), where COMT gene disruption 
resulted in sex-mediated differences in ethanol intake in mice. Specifically, male mice with 
COMT gene disruptions consumed more ethanol than wild type mice and, while females 
consumed more ethanol than males, there was no effect of COMT gene disruption on their 
ethanol intake (Tammimäki et al. 2008).  Interactions between sex and COMT genotype have 
also been observed in behavioral responses to pharmacological challenges. Male and female 
mice showed different responses to amphetamine-induced locomotor activity where male mice 
homozygous for COMT deletion showed enhanced activity, an effect not observed in female 
homozygotes or wild type animals  (Huotari et al., 2004). Moreover, sex differences in 
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pharmacological therapies for AUD have been reported where naltrexone in combination with 
topiramate reduced responding for ethanol in male rats to a greater extent than in female rats 
(Moore and Lynch, 2015). Consistent with these findings, in the current experiments, female 
behavior was not sensitive to pharmacological manipulations of COMT. However, it is possible 
that a higher dose is required in females. Additionally, in mice, sex/COMT genotype interactions 
were observed in a behavioral measure of impulsivity (Papaleo et al., 2012), a phenotype 
associated with addiction disorders (Perry and Carroll, 2008).  Lastly, sex differences in COMT 
inhibition on catecholamine metabolism have been observed in rats (Laatikainen et al., 2013). 
Estrogen decreases COMT activity as well as gene and protein expression (Cohn and Axelrod, 
1971; Jiang et al., 2003). Sex specific compensatory mechanisms may therefore account for 
interactions between sex, COMT, and behavior (Harrison and Tunbridge, 2008). The present 
experiments add to a growing body of  literature which suggest that COMT genotype has 
sexually dimorphic effects on behavior (Harrison and Tunbridge, 2008).  
COMT protein expression was investigated as a potential mechanism by which tolcapone 
may differentially affect male and female P and Wistar rats. COMT protein levels in the PFC 
were lower in P rats compared to Wistars but female P rats expressed greater levels of COMT in 
the PFC relative to males. Engleman et al. (2006) reported that P rats exhibited lower 
extracellular DA levels relative to Wistars which may result in a down regulation of COMT 
expression.  Importantly, strain differences in PFC DA tone were only previously assessed in 
male rats (Engleman et al., 2006), making it unclear whether or not this strain difference is 
present in females. The current studies assessed levels of COMT protein but not enzymatic 
activity of COMT.  While allelic variations in COMT have been modeled in mice (Papaleo et al., 
2008; Risbrough et al., 2014), to date no such rat models exist. However, mice with increased 
COMT activity show deficits in attentional processes (Papaleo et al., 2008) and response 
inhibition (Simpson et al., 2014) similar to individuals with AUD (Noel et al., 2007; Vollstadt-
Klein et al., 2012) and P rats (Beckwith and Czachowski, 2014; Beckwith and Czachowski, 
2016; Linsenbardt et al., 2016).  Additionally, polymorphisms of the COMT gene are 
characterized by differences in enzyme activity (Chen et al., 2004) and these differences are 
associated with alterations in executive functioning (Egan et al., 2001; Farrell et al., 2012). Thus, 
greater enzymatic activity of COMT in P rats may explain reduced cortical DA tone and COMT 
protein levels relative to Wistars. Similar to observations in clinical populations (Farrell et al., 
2012; Mattay et al., 2003), animals with greater enzymatic activity may show increased 
sensitivity to pharmacological compounds which target PFC DA and PFC-mediated behaviors. 
Differences in COMT metabolism of DA may underlie the behavioral differences reported here, 
but future studies are needed to fully explore these possibilities.  
The efficacy of tolcapone in male rats for each of the reinforcers tested here may be 
associated with differences in PFC function. It has been hypothesized that the PFC encodes, 
among other things, subjective value (Kable and Glimcher, 2007). Therefore, the efficacy of 
tolcapone in the PSSD task may be mediated by each animal’s appraisal of its respective 
reinforcer. This is consistent with the non-ethanol specific effects of tolcapone on consummatory 
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behavior in P rats which may be due to the perceived value of reward in these animals which 
show excessive reward consumption for both ethanol and sucrose (McCane et al., 2014). In fact, 
Shnitko and Robinson (2014) recently reported statistically indistinguishable cue-evoked striatal 
DA activity in ethanol- and sucrose-reinforced rats. The authors posited that these results may 
indicate that both solutions were equally reinforcing, evident by similar operant responding in 
both groups (Shnitko and Robinson, 2014). Cue-evoked DA release is consistently reported 
(Brown et al., 2011; Fotros et al., 2013) and is hypothesized to play a role in encoding of salient 
stimuli (Berridge and Robinson, 1998). Enhancement of DA tone may shift the signal to noise 
ratio (Servan-Schreiber et al., 1990), dampening the effects of stimulus presentation on 
subsequent behavior. Under this hypothesis, in the current experiments, a tolcapone-mediated 
suppression of cue salience may lead to a reduction in reward seeking and consumption. 
Subjective value assigned to a reinforcing substance would influence the salience that one 
attributes to cues predictive of said substance. Importantly, the nonspecific nature of tolcapone’s 
effects on reinforcers in general suggests that COMT inhibition may possess clinical utility in 
treatment of addiction disorders broadly.  
Given innate differences in PFC DA tone between P and Wistar rats (Engleman et al., 
2006), coupled with our findings that COMT expression differs by strain and sex in the PFC, we 
hypothesize that tolcapone exerts its effects primarily on cortical catecholamines. However, high 
COMT expression in the hippocampus has also been reported (Matsumoto et al., 2003) and 
tolcapone affects hippocampal DA and behavior in hippocampus-mediated tasks (Laatikainen et 
al., 2012; Laatikainen et al., 2013). Furthermore, hippocampal DA has been hypothesized to 
contribute to attribution of incentive salience (Fotros et al., 2013). Thus in the present 
experiments, it is unclear to what extent hippocampal DA levels may contribute to tolcapone-
mediated changes in drinking behaviors. Experiments that seek to tease apart the involvement of 
DA transmission in the hippocampus versus PFC in ethanol-motivated responding are thus 
warranted. 
Collectively, these data suggest the potential clinical utility of COMT inhibitors for the 
treatment of addiction disorders. Similar to current pharmacotherapies such as naltrexone, 
tolcapone’s effects were not ethanol specific, therefore tolcapone may be effective in reducing 
other drug reinforced behaviors and should be investigated accordingly. Importantly, the degree 
to which tolcapone may suppress natural reinforcers in clinical populations is unknown, and as 
such, future clinical studies should exercise caution when working with this compound. It should 
be noted that the differential effects in P rats and Wistars suggest that this compound may be 
more efficacious for “at risk” populations susceptible to drug abuse. Preclinical findings support 
this hypothesis where allelic variation of the COMT gene was associated with differences in 
tolcapone’s efficacy in ameliorating cognitive deficits (Farrell et al., 2012; Grant et al., 2013). 
Tolcapone’s sex specific effects are consist with observations made in COMT deficient mice 
(Tammimäki et al., 2008) and suggest that sex differences in COMT activity may be associated 
with differences in the neurophysiological  mechanisms underlying drinking behaviors (Harrison 
and Tunbridge, 2008). Lastly, it should be noted that sex and strain differences in 
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pharmacokinetics may underlie the results attained here, and should be considered as a caveat to 
be investigated in future studies. Overall however, the behavior-specific effects observed suggest 
this compound may hold promise as a means to remediate reward seeking behaviors, indicating 
that COMT inhibitors should be investigated as a tool to mitigate reward craving and reduce 
propensity to relapse.  
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Figure 1. Ethanol intake in the intermittent access protocol for female (square) and male (circle) P (open) 
and Wistar (closed) rats. P rats consume more ethanol compared to their Wistar counterparts. Female rats 
of both strains consume more EtOH than males.  
 
 
Figure 2. Sucrose intake in the intermittent access protocol for male P (open) and Wistar (closed) rats. P 
rats consume more sucrose than Wistars and show an escalation in intake over days.  
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Figure 3. EtOH (A) and Sucrose (B) intake in male (A1,B) and female (A2) rats during the consummatory 
test phase. Tolcapone reduces both ethanol and sucrose consumption in male P rats. *main effect of 
treatment, p<0.05 
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Figure 4. Lever press responding in EtOH (A) and Sucrose 
(B) reinforced male (A1,B) and female (A2) rats during the 
appetitive testing phase. Tolcapone reduced responding in 
male P and Wistar rats, regardless of reinforcer group. This 
effect was driven by the 30 mg/kg dose of Tolcapone. *main 
effect of treatment, p<0.05. # Dunnett’s post hoc, dose 
different from vehicle, p<0.05.  
 
Figure 5. Protein expression in the PFC, hippocampus (HC) 
and striatum of male and female P and Wistar rats. COMT 
levels in male P and Wistar rats, show that P rats exhibit 
reduced COMT expression in all brain regions, relative to 
Wistars (A). COMT levels compared between male and 
female Wistars show no sex differences in any region 
assessed (B).  However, in P rats, male P rats exhibit reduced 
COMT expression compared to females (C). *p<0.05, 
**p<0.01, ***p<0.001 
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Highlights 
• The effects of COMT inhibition on alcohol seeking and drinking were examined.  
• Sex and strain differences in COMT expression were examined.  
• Tolcapone reduces reinforcer intake and seeking in male alcohol preferring P rats 
• Tolcapone had no effect on consumption or seeking in female rats  
• Sex and strain differences in COMT expression were observed in the PFC  
 
